Branded Generics In Emerging Countries: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023
Branded Generics In Emerging Countries: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023
Branded Generics In Emerging Countries:
By Disease Indication (Cardiovascular Diseases, Diabetes, Cancer, Neurological Disorders, Gastrointestinal Diseases, Dermatology Diseases, and Others), By Route of Administration (Oral, Parenteral, Topical, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Branded Generics in Emerging Countries Report Description:
Branded Generics in Emerging Countries report gives the comprehensive outlook on branded generics across the emerging countries with special emphasis on key regions such as BRICS, ASEAN, and Latin America regions. This report onbranded generics in emerging countries gives historical, current, and future market sizes (US$ Mn) of disease indications, route of administration, distribution channels, and geographic regions. This report studies branded generics market dynamics in emerging countries elaborately to identify the current trends & drivers, future market opportunities and possible challenges to the key stakeholders operating in the market. In addition, branded generics in the emerging countries report includes new product introductions, recent drug patent expiration data, regulatory scenario, collaborations & distribution agreements and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the branded generics market in emerging countries to better equip the clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Disease Opportunities). Key stakeholders of the branded generics in emerging countries report include suppliers, manufacturers, marketers, engaged in manufacturing and supply of pharmaceutical products.
A sample of this report is available upon request @
Branded Generics in Emerging Countries:
The Branded Generics Market in Emerging countries estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017 to 2023. The market for branded generics projected to reach US$ XX Mn by 2023 owing to rise in out-of-pocket healthcare expenditure and availability of large untapped market.
Rise in out-of-pocket healthcare expenditure and vast market opportunities expected to drive market revenue growth significantly
The healthcare spending as % of total private healthcare expenditure is high in major countries such as India, China, and Brazil, which is likely to impact market growth positively over the forecast period. For instance in 2014, According to World Bank global health expenditure database, Out-of-pocket health expenditure (% of private expenditure on health) in India and China were 89.2% and 72.3% respectively. Moreover, several countries in emerging markets witnessing growing middle-class and rise in incomes, which is expected to create significant demand for branded generics in the emerging countries. In addition, emerging countries account for more than 50% of branded generics sales across the globe, this helps the multinational and local pharmaceutical companies to capitalize the ever-growing market opportunities in the region.
Governments pushing for low-cost drugs to improve market access
The rising demand for affordable and high-quality medicines in emerging countries and local government’s initiative improve the healthcare access by means of building healthcare infrastructure and price regulations paving the way for branded generics, which enjoys loyalty from larger stakeholders. Moreover, the mixed demographic profile, rising chronic diseases creating the demand for high quality branded drugs in the emerging countries. However, unique players need to understand the unique challenge of access and affordability in the region to withstand current market competition and to derive the long-term strategy.
To view TOC of this report is available upon request @
Asia-Pacific region leads the market with higher revenue share and growth
Asia-pacific region leads thebranded generics market in emerging countries in terms of revenue in 2016 and projected to remain dominant across the forecast period owing to high out-of-pocket healthcare expenditure, rising prevalence of chronic diseases, and growing middle-class population. Latin America presented better growth opportunities for the market players.
Competition Assessment
Key players profiled in the globalBranded Generics in Emerging Countries include:
- Abbott Laboratories (U.S.)
- Apotex Inc. (Canada)
- AstraZeneca (U.K)
- CSPC Pharmaceutical Group Limited. (China)
- Reddy’s Laboratories Ltd. (India)
- GlaxoSmithKline plc (U.K)
- Mylan N.V. (U.S.)
- Novartis AG (Switzerland)
- Pfizer Inc. (U.S)
- Sanofi (France)
- Sun Pharmaceutical Industries Ltd. (India)
- Teva Pharmaceutical Industries Ltd (Israel)
- Valeant Pharmaceuticals International, Inc. (Canada)
- Nichi-Iko Pharmaceutical Co., Ltd ( Japan)
Market players are focusing on mergers and acquisitions to improve their market position in emerging countries. For instance, in 2016, Sun pharma acquired Russian drug maker Biosintez as to step up focus on emerging countries.
Need more information about this report @
Key Findings of the Report:
- Branded Generics Countries in emerging countries expanding at XX% CAGR over 2017 to 2013 to reach market value of US$ XX Mn by 2023
- Based on diseases indication, cardiovascular diseases sub-segment accounted for larger market share in 2016 and projected to dominate throughout the forecast period
- Retail pharmacies are prime distribution channels for branded generics in emerging countries owing to wider accessibility
- Players focusing on mergers and acquisitions to expand geographic presence to garner market opportunities in developing economies
Key Features of the Report:
- The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Detailed Segmentation
By Diseases Indication
- Cardiovascular Diseases
- Diabetes
- Cancer
- Neurological Disorders
- Gastrointestinal Diseases
- Dermatology Diseases
- Others
By Route of Administration
- Oral
- Parenteral
- Topical
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
Geography
- Asia-Pacific
- China
- India
- ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
- Rest of Asia- Pacific
- Latin America
- Brazil
- Poland
- Argentina
- Mexico
- Venezuela
- Rest of Latin America
- Europe
- Russia
- Romania
- Rest of Europe
- Rest of the World (RoW)
- Turkey
- Saudi Arabia
- South Africa
- Egypt
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/branded-generics-in-emerging-countries/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @https://www.precisionbusinessinsights.com
Bacchanal Buffet to Reopen at Caesars Palace on May 20
